Insider Trading activities of Nabi Biopharmaceuticals insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nabi Biopharmaceuticals since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nabi Biopharmaceuticals since year 2005. Table 2 shows the detailed insider transactions of Nabi Biopharmaceuticals since 2005. The reporting company's ticker symbol is BOTA. The reporting company's CIK number is 72444.
The total value of stock buying since 2005 is $6,906,552.
The total value of stock sales since 2005 is $7,996,321.
The total value of stock option exercises since 2005 is $13,330.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nabi Biopharmaceuticals (BOTA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-02 7,000 $9,814 0 $0 0 $0
2015-09 5,000 $9,340 0 $0 0 $0
2015-06 105,000 $216,195 0 $0 0 $0
2015-03 20,000 $45,679 0 $0 0 $0
2014-06 61,498 $174,595 0 $0 0 $0
2012-04 0 $0 5,167 $9,817 0 $0
2011-05 0 $0 12,376 $68,092 0 $0
2011-04 0 $0 28,179 $162,461 0 $0
2011-03 0 $0 33,000 $190,965 0 $0
2011-01 0 $0 6,166 $34,840 0 $0
2010-12 0 $0 28,405 $160,460 0 $0
2010-11 0 $0 30,695 $163,021 0 $0
2010-10 0 $0 24,995 $125,060 0 $0
2010-07 0 $0 3,125 $17,575 0 $0
2010-06 0 $0 3,605 $20,711 0 $0
2010-05 5,724 $29,992 15,000 $85,725 0 $0
2010-04 0 $0 9,448 $51,751 0 $0
2010-03 0 $0 349,385 $2,088,341 3,375 $13,330
2010-01 0 $0 191,965 $1,033,730 0 $0
2009-12 0 $0 12,080 $63,298 0 $0
2009-11 3,000 $14,940 478,345 $2,273,594 0 $0
2009-06 0 $0 199,600 $496,692 0 $0
2009-01 58,500 $224,640 0 $0 0 $0
2008-04 0 $0 120,000 $489,000 0 $0
2008-03 0 $0 85,620 $291,121 0 $0
2007-05 1,140,000 $5,921,200 0 $0 0 $0
2006-11 27,342 $170,887 27,342 $170,067 0 $0
2005-11 15,000 $52,800 0 $0 0 $0
2005-06 2,000 $24,300 0 $0 0 $0
2005-05 1,000 $12,170 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nabi Biopharmaceuticals insiders (BOTA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-02-09 Colonnese Mark P (Chief Financial Officer) Buy 7,000 1.40 9,814
2015-09-25 Patti Joseph M (CEO) Buy 5,000 1.87 9,340
2015-06-22 Vanlent Anne (Director) Buy 35,000 2.20 76,895
2015-06-09 Fox James (Director) Buy 70,000 1.99 139,300
2015-03-27 Patti Joseph M (CEO) Buy 20,000 2.28 45,679
2014-06-30 Patti Joseph M (EVP, Corporate Dev & Strategy) Buy 10,000 2.86 28,600
2014-06-27 Patti Joseph M (EVP, Corporate Dev & Strategy) Buy 5,000 2.80 13,975
2014-06-11 Plumb Russell H (CEO & President) Buy 29,331 2.96 86,761
2014-06-11 Patti Joseph M (EVP, Corporate Dev & Strategy) Buy 5,616 2.89 16,207
2014-06-10 Plumb Russell H (CEO & President) Buy 2,700 2.45 6,615
2014-06-10 Patti Joseph M (EVP, Corporate Dev & Strategy) Buy 8,851 2.54 22,437
2012-04-05 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 5,167 1.90 9,817
2011-05-16 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 12,376 5.50 68,092
2011-04-05 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 8,596 5.76 49,478
2011-04-05 Fahim Raafat E F (President, CEO and CFO) Sale 13,283 5.76 76,456
2011-04-01 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 6,300 5.80 36,527
2011-03-15 Aryeh Jason (Director) Sale 4,900 5.87 28,763
2011-03-14 Aryeh Jason (Director) Sale 3,400 5.84 19,856
2011-03-11 Aryeh Jason (Director) Sale 24,700 5.76 142,346
2011-01-05 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 2,985 5.65 16,868
2011-01-05 Fahim Raafat E F (President, CEO and CFO) Sale 3,181 5.65 17,972
2010-12-27 Aryeh Jason (Director) Sale 15,093 5.74 86,633
2010-12-15 Aryeh Jason (Director) Sale 1,907 5.74 10,946
2010-12-08 Aryeh Jason (Director) Sale 4,705 5.49 25,830
2010-12-01 Aryeh Jason (Director) Sale 6,700 5.53 37,051
2010-11-22 Aryeh Jason (Director) Sale 2,832 5.25 14,868
2010-11-19 Aryeh Jason (Director) Sale 463 5.25 2,430
2010-11-18 Aryeh Jason (Director) Sale 4,900 5.24 25,676
2010-11-11 Aryeh Jason (Director) Sale 4,900 5.30 25,970
2010-11-10 Aryeh Jason (Director) Sale 11,200 5.39 60,401
2010-11-09 Aryeh Jason (Director) Sale 6,400 5.26 33,676
2010-10-20 Aryeh Jason (Director) Sale 8,553 5.01 42,850
2010-10-18 Aryeh Jason (Director) Sale 12,020 5.00 60,100
2010-10-11 Aryeh Jason (Director) Sale 4,422 5.00 22,110
2010-07-26 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 1,500 5.78 8,670
2010-07-19 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 1,625 5.48 8,905
2010-06-11 Aryeh Jason (Director) Sale 2,747 5.74 15,768
2010-06-03 Aryeh Jason (Director) Sale 258 5.81 1,498
2010-05-20 Davis Peter B (Director) Buy 3,816 5.24 19,995
2010-05-20 Cox Geoffrey F (Director) Buy 1,908 5.24 9,997
2010-05-17 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 15,000 5.72 85,725
2010-04-13 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 2,250 5.78 13,005
2010-04-05 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 5,248 5.35 28,055
2010-04-01 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 1,950 5.48 10,691
2010-03-24 Aryeh Jason (Director) Sale 234 6.24 1,460
2010-03-23 Aryeh Jason (Director) Sale 64,793 6.25 404,826
2010-03-22 Aryeh Jason (Director) Sale 28,510 6.24 177,902
2010-03-19 Aryeh Jason (Director) Sale 7,800 5.99 46,722
2010-03-18 Aryeh Jason (Director) Sale 6,581 5.96 39,255
2010-03-17 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 9,873 5.93 58,546
2010-03-17 Aryeh Jason (Director) Sale 11,419 5.95 67,943
2010-03-15 Aryeh Jason (Director) Sale 200 5.93 1,186
2010-03-12 Aryeh Jason (Director) Sale 16,600 5.93 98,404
2010-03-11 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 1,125 5.95 6,693
2010-03-11 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Option Ex 1,125 3.95 4,443
2010-03-11 Aryeh Jason (Director) Sale 180,700 5.88 1,062,335
2010-03-10 Aryeh Jason (Director) Sale 16,100 5.74 92,414
2010-03-08 Aryeh Jason (Director) Sale 3,200 5.75 18,393
2010-03-02 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 2,250 5.45 12,262
2010-03-02 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Option Ex 2,250 3.95 8,887
2010-01-13 Aryeh Jason (Director) Sale 13,800 5.49 75,775
2010-01-12 Aryeh Jason (Director) Sale 86,200 5.49 473,410
2010-01-08 Aryeh Jason (Director) Sale 46,157 5.29 244,170
2010-01-07 Aryeh Jason (Director) Sale 3,443 5.29 18,213
2010-01-06 Aryeh Jason (Director) Sale 42,365 5.24 222,162
2009-12-22 Aryeh Jason (Director) Sale 8,035 5.24 42,103
2009-12-16 Aryeh Jason (Director) Sale 4,045 5.24 21,195
2009-11-23 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 602 5.00 3,011
2009-11-23 Davis Peter B (Director) Buy 3,000 4.98 14,940
2009-11-20 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 15,638 4.90 76,704
2009-11-19 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 2,500 4.90 12,250
2009-11-17 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 6,900 4.97 34,299
2009-11-17 Aryeh Jason (Director) Sale 185,909 4.99 928,429
2009-11-17 Lynch Timothy P (Director) Sale 3,846 5.20 19,999
2009-11-16 Kalnik Matthew W. (SVP Strategic Plan. & Bus. Ops) Sale 7,674 4.47 34,333
2009-11-16 Aryeh Jason (Director) Sale 255,276 4.56 1,164,569
2009-06-30 Knott David M (10% Owner) Sale 90,000 2.45 220,500
2009-06-29 Knott David M (10% Owner) Sale 109,600 2.52 276,192
2009-01-12 Knott David M (10% Owner) Buy 58,500 3.84 224,640
2008-04-03 Hudson Leslie (Director) Sale 72,000 4.08 293,400
2008-03-10 Siegel Jordan I (Sr. VP Fin. & Admin, CFO Treas) Sale 67,500 3.30 222,750
2008-03-05 Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) Sale 3,120 3.75 11,687
2008-03-05 Siegel Jordan I (Sr. VP Fin. & Admin, CFO Treas) Sale 7,500 3.80 28,462
2008-03-05 Fahim Raafat E F (President and CEO) Sale 7,500 3.76 28,222
2007-05-10 Loeb Daniel S (Other) Buy 335,000 5.25 1,758,750
2007-05-09 Loeb Daniel S (Other) Buy 225,000 5.25 1,181,250
2007-05-08 Loeb Daniel S (Other) Buy 580,000 5.14 2,981,200
2006-11-03 Loeb Daniel S (Other) Buy 27,342 6.25 170,887
2006-11-03 Loeb Daniel S (Other) Sale 27,342 6.22 170,067
2005-11-04 Jooste H Le Roux (Mktng.) Buy 10,000 3.55 35,500
2005-11-03 Fahim Raafat E F (Prod.) Buy 5,000 3.46 17,300
2005-06-08 Fahim Raafat E F (Prod.) Buy 2,000 12.15 24,300
2005-05-20 Fahim Raafat E F (Prod.) Buy 1,000 12.17 12,170

Insider trading activities including stock purchases, stock sales, and option exercises of BOTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nabi Biopharmaceuticals (symbol BOTA, CIK number 72444) see the Securities and Exchange Commission (SEC) website.